AXGN: Investor Sentiment and Bull/Bear Views
Axogen, Inc.
Loading...
Loading...
Buzzberg insights
Attention & activity
- unique authors
- 0
- vs usual
- -100%
24h0
30d avg / day0.1
- unique authors
- 1
- vs usual
- +300%
7d1
4wk avg / week0.2
Author calls
What authors recommend
- Long
- —Authors: 0
- Short
- —Authors: 0
- Avoid
- —Authors: 0
- Long
- —Authors: 0
- Short
- —Authors: 0
- Avoid
- —Authors: 0
Author positions
What authors disclose
- Long
- —Authors: 0
- Short
- —Authors: 0
- Trimmed
- —Authors: 0
- Closed
- —Authors: 0
- Long
- —Authors: 0
- Short
- —Authors: 0
- Trimmed
- —Authors: 0
- Closed
- —Authors: 0
Feed & authors
- ideas
- 4
- Authors
- 4
- Sources
- 4
Call performance
Performance since each author’s call.
| Author | Direction | Return |
|---|---|---|
| u/surveytigerJan 08 | Long | +60.8% |
Best calls over the past year · return since each call
Company facts
- Market cap
- $3.31B 2026-11-16
Financial results are not available yet.
Financial details
Market cap · polygon · 2026-11-16
Sentiment
Attention
0-100%vs usual
unique authors
30d avg / day 0.1
Attention
1+300%vs usual
unique authors
4wk avg / week 0.2
Loading chart...
Time
Author
Thesis
Company / ticker
Signal
Since call
Position
Source
17:32
Jan 08
Jan 08
r/smallstreetbets
Reddit
Axogen's Avance FDA approval may improve insurance reimbursement.
The author argues Axogen's Avance nerve graft received FDA approval last month. They expect insurers to treat an FDA-approved product more favorably for reimbursement. This reimbursement shift could benefit Axogen this year.